Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 22

1.

Prevalence and Predictors of Clozapine-Associated Constipation: A Systematic Review and Meta-Analysis.

Shirazi A, Stubbs B, Gomez L, Moore S, Gaughran F, Flanagan RJ, MacCabe JH, Lally J.

Int J Mol Sci. 2016 Jun 2;17(6). pii: E863. doi: 10.3390/ijms17060863. Review.

2.

Activating and Tranquilizing Effects of First-Time Treatment with Aripiprazole, Olanzapine, Quetiapine, and Risperidone in Youth.

Al-Dhaher Z, Kapoor S, Saito E, Krakower S, David L, Ake T, Kane JM, Correll CU, Carbon M.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):458-70. doi: 10.1089/cap.2015.0141. Epub 2016 Apr 19.

3.

Strong Treatment Response and High Maintenance Rates of Clozapine in Childhood-Onset Schizophrenia.

Kasoff LI, Ahn K, Gochman P, Broadnax DD, Rapoport JL.

J Child Adolesc Psychopharmacol. 2016 Jun;26(5):428-35. doi: 10.1089/cap.2015.0103. Epub 2016 Jan 19.

4.

Comparative efficacy between clozapine and other atypical antipsychotics on depressive symptoms in patients with schizophrenia: analysis of the CATIE phase 2E data.

Nakajima S, Takeuchi H, Fervaha G, Plitman E, Chung JK, Caravaggio F, Iwata Y, Mihashi Y, Gerretsen P, Remington G, Mulsant B, Graff-Guerrero A.

Schizophr Res. 2015 Feb;161(2-3):429-33. doi: 10.1016/j.schres.2014.12.024. Epub 2014 Dec 30.

5.

Current status of clozapine in the United States.

Kelly DL, Wehring HJ, Vyas G.

Shanghai Arch Psychiatry. 2012 Apr;24(2):110-3. doi: 10.3969/j.issn.1002-0829.2012.02.007. No abstract available.

6.

Almost all antipsychotics result in weight gain: a meta-analysis.

Bak M, Fransen A, Janssen J, van Os J, Drukker M.

PLoS One. 2014 Apr 24;9(4):e94112. doi: 10.1371/journal.pone.0094112. eCollection 2014.

7.

Clinical features of schizophrenia with enhanced carbonyl stress.

Miyashita M, Arai M, Kobori A, Ichikawa T, Toriumi K, Niizato K, Oshima K, Okazaki Y, Yoshikawa T, Amano N, Miyata T, Itokawa M.

Schizophr Bull. 2014 Sep;40(5):1040-6. doi: 10.1093/schbul/sbt129. Epub 2013 Sep 23.

8.

Combination and high-dose atypical antipsychotic therapy in patients with schizophrenia: systematic review.

[No authors listed]

CADTH Technol Overv. 2012;2(3):e2301. Epub 2012 Sep 1. No abstract available.

9.

Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.

Macdonald K, Feifel D.

Acta Neuropsychiatr. 2012 Jun;24(3):130-46. doi: 10.1111/j.1601-5215.2011.00634.x. Epub 2011 Dec 19.

10.

Concept and Management of Treatment Resistant Schizophrenia (TRS).

Painuly N, Gupta N, Avasthi A.

Indian J Psychiatry. 2004 Apr;46(2):125-34.

11.

Risperidone versus other atypical antipsychotics for schizophrenia.

Komossa K, Rummel-Kluge C, Schwarz S, Schmid F, Hunger H, Kissling W, Leucht S.

Cochrane Database Syst Rev. 2011 Jan 19;(1):CD006626. doi: 10.1002/14651858.CD006626.pub2. Review.

12.

Clozapine versus other atypical antipsychotics for schizophrenia.

Asenjo Lobos C, Komossa K, Rummel-Kluge C, Hunger H, Schmid F, Schwarz S, Leucht S.

Cochrane Database Syst Rev. 2010 Nov 10;(11):CD006633. doi: 10.1002/14651858.CD006633.pub2. Review.

13.

Impact of second-generation antipsychotics and perphenazine on depressive symptoms in a randomized trial of treatment for chronic schizophrenia.

Addington DE, Mohamed S, Rosenheck RA, Davis SM, Stroup TS, McEvoy JP, Swartz MS, Lieberman JA.

J Clin Psychiatry. 2011 Jan;72(1):75-80. doi: 10.4088/JCP.09m05258gre. Epub 2010 Sep 21.

14.

Clozapine: Current perspective.

Solanki RK, Singh P, Swami MK.

Indian J Psychiatry. 2007 Oct;49(4):271-6. doi: 10.4103/0019-5545.37668.

15.

Clozapine: a distinct, poorly understood and under-used molecule.

Joober R, Boksa P.

J Psychiatry Neurosci. 2010 May;35(3):147-9. No abstract available.

16.

Changes in clinical trials methodology over time: a systematic review of six decades of research in psychopharmacology.

Brunoni AR, Tadini L, Fregni F.

PLoS One. 2010 Mar 3;5(3):e9479. doi: 10.1371/journal.pone.0009479. Review.

17.

Glutamatergic dysfunction in schizophrenia: from basic neuroscience to clinical psychopharmacology.

Paz RD, Tardito S, Atzori M, Tseng KY.

Eur Neuropsychopharmacol. 2008 Nov;18(11):773-86. doi: 10.1016/j.euroneuro.2008.06.005. Epub 2008 Jul 23. Review.

18.

Dropout rates in randomized clinical trials of antipsychotics: a meta-analysis comparing first- and second-generation drugs and an examination of the role of trial design features.

Rabinowitz J, Levine SZ, Barkai O, Davidov O.

Schizophr Bull. 2009 Jul;35(4):775-88. doi: 10.1093/schbul/sbn005. Epub 2008 Feb 26.

19.

Comparison of clozapine response for inpatients in the research setting versus routine clinical practice.

Boggs DL, Kelly DL, Love RC, McMahon RP, Conley RR.

Psychiatr Q. 2008 Jun;79(2):111-9. doi: 10.1007/s11126-008-9067-1. Epub 2008 Jan 24.

20.

An initial animal proof-of-concept study for central administration of clozapine to schizophrenia patients.

Abrams DJ, Zheng L, Choo KS, Yang JJ, Wei W, Anchordoquy TJ, Zawia NH, Stevens KE.

Schizophr Res. 2008 Mar;100(1-3):86-96. doi: 10.1016/j.schres.2007.10.012. Epub 2008 Jan 7.

Supplemental Content

Support Center